| Hepatic and intestinal schistosomiasis T Elbaz, G Esmat Journal of advanced research 4 (5), 445-452, 2013 | 250 | 2013 |
| Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium JD Yang, EA Mohamed, AOA Aziz, HI Shousha, MB Hashem, MM Nabeel, ... The lancet Gastroenterology & hepatology 2 (2), 103-111, 2017 | 247 | 2017 |
| Human Schistosomiasis: Clinical perspective. Review R Barsoum, G Esmat, T Elbaz Journal of Advanced Research 4, 445-452., 2013 | 240* | 2013 |
| Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real‐world results from 18 378 patients in Egypt H Omar, W El Akel, T Elbaz, M El Kassas, K Elsaeed, H El Shazly, M Said, ... Alimentary pharmacology & therapeutics 47 (3), 421-431, 2018 | 139 | 2018 |
| Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience A Abdelaziz, T Elbaz, HI Shousha, S Mahmoud, M Ibrahim, ... Surgical endoscopy 28, 3429-3434, 2014 | 139 | 2014 |
| New era for management of chronic hepatitis C virus using direct antiviral agents: a review T Elbaz, M El-Kassas, G Esmat Journal of advanced research 6 (3), 301-310, 2015 | 72 | 2015 |
| Machine learning prediction models for diagnosing hepatocellular carcinoma with HCV-related chronic liver disease S Hashem, M ElHefnawi, S Habashy, M El-Adawy, G Esmat, W Elakel, ... Computer methods and programs in biomedicine 196, 105551, 2020 | 70 | 2020 |
| Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients R Eletreby, W Elakel, M Said, M El Kassas, S Seif, T Elbaz, M El Raziky, ... Liver International 37 (4), 534-541, 2017 | 68 | 2017 |
| Microwave ablation versus transarterial chemoembolization in large hepatocellular carcinoma: prospective analysis AO Abdelaziz, MM Nabeel, TM Elbaz, HI Shousha, EM Hassan, ... Scandinavian Journal of Gastroenterology 50 (4), 479-484, 2015 | 65 | 2015 |
| Survival and prognostic factors for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience AO Abdelaziz, TM Elbaz, HI Shousha, MM Ibrahim, MAR El-Shazli, ... Asian Pacific Journal of Cancer Prevention 15 (9), 3915-3920, 2014 | 58 | 2014 |
| Value of microwave ablation in treatment of large lesions of hepatocellular carcinoma E Medhat, A Abdel Aziz, M Nabeel, T Elbaz, Z Zakaria, H Shousha, ... Journal of Digestive Diseases 16 (8), 456-463, 2015 | 56 | 2015 |
| HCV in Egypt, prevention, treatment and key barriers to elimination M El Kassas, T Elbaz, A Elsharkawy, H Omar, G Esmat Expert review of anti-infective therapy 16 (4), 345-350, 2018 | 55 | 2018 |
| Safety of direct antiviral agents in the management of hepatitis C M El Kassas, T Elbaz, E Hafez, G Esmat Expert opinion on drug safety 15 (12), 1643-1652, 2016 | 47 | 2016 |
| Transarterial chemoembolization combined with either radiofrequency or microwave ablation in management of hepatocellular carcinoma AO Abdelaziz, AH Abdelmaksoud, MM Nabeel, HI Shousha, AA Cordie, ... Asian Pacific Journal of Cancer Prevention: APJCP 18 (1), 189, 2017 | 42 | 2017 |
| Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma N El-Abd, A Fawzy, T Elbaz, S Hamdy Tumor Biology 37, 211-216, 2016 | 41 | 2016 |
| RETRACTED ARTICLE: Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: A multicenter Egyptian study M El-Bendary, S Abd-Elsalam, T Elbaz, W El-Akel, A Cordie, T Elhadidy, ... Expert Review of Anti-infective Therapy 20 (2), 291-295, 2022 | 38 | 2022 |
| Tumor behavior of hepatocellular carcinoma after hepatitis C treatment by direct-acting antivirals: comparative analysis with non-direct-acting antivirals-treated patients AO Abdelaziz, MM Nabil, AH Abdelmaksoud, HI Shousha, MB Hashem, ... European journal of gastroenterology & hepatology 31 (1), 75-79, 2019 | 36 | 2019 |
| Pregnancy outcome of anti‐HCV direct‐acting antivirals: real‐life data from an Egyptian cohort M AbdAllah, M Alboraie, W Abdel‐Razek, M Hassany, I Ammar, E Kamal, ... Liver International 41 (7), 1494-1497, 2021 | 32 | 2021 |
| Efficacy and safety of sofosbuvir and daclatasvir with or without ribavirin in elderly patients with chronic hepatitis C virus infection T Elbaz, M Abdo, H Omar, EA Hassan, AM Zaghloul, M Abdel‐Samiee, ... Journal of Medical Virology 91 (2), 272-277, 2019 | 32 | 2019 |
| Effectiveness of ravidasvir plus sofosbuvir in interferon-naïve and treated patients with chronic hepatitis C genotype-4 G Esmat, T Elbaz, M El Raziky, A Gomaa, M Abouelkhair, HG El Deen, ... Journal of hepatology 68 (1), 53-62, 2018 | 32 | 2018 |
